Rapid detection of extended-spectrum β-lactamase-producing bacteria using DPS192iX

Bibliographic Information

Other Title
  • DPS192iXを使用したExtended Spectrum β-lactamase産生菌の迅速検出に関する検討

Search this article

Description

<p>Drug-resistant gram-negative bacilli have recently emerged as a major problem worldwide. The production of extended-spectrum β-lactamases (ESBLs) is an important resistance mechanism of pathogenic bacteria, which impedes the treatment of infections caused by gram-negative bacilli with drugs. Therefore, there is a compelling need to develop rapid detection methods for ESBL-producing bacteria. Herein, we evaluated the performance of a drug-susceptibility measurement instrument, DPS192iX (Eiken Chemical Co., Ltd.) for the rapid detection of ESBL-producing bacteria using various β-lactamase-producing Enterobacteriaceae strains. Seventy-one β-lactamase-producing strains were used for the analysis. The concordance between detection rates (within +/−1 difference in each tube) was >94% for all test agents compared with those obtained by the conventional method. The detection rates of 28 ESBL-producing strains were high: 96% for CTX, 68% for CAZ, 93% for CPR, and 96% for CPDX at 18 hours and 75% for CTX and 96% for CPDX at 5 hours. At 18 hours, all the ESBL-producing strains were detected using at least one of the agents. The results obtained should, however, be carefully examined because they depend on the genotypes of the ESBL-producing strains. Nevertheless, the drug susceptibilities of various β-lactamase-producing Enterobacteriaceae strains can be determined with high accuracy by using DPS192iX in routine tests. In addition, the ESBL-producing strains can be rapidly detected by using DPS192iX. In conclusion, the findings of this study demonstrate that the use of DPS192iX could ensure the proper use of antibiotics and thus contribute to the development of control measures against hospital infections caused by drug-resistant bacteria.</p>

Journal

Details 詳細情報について

Report a problem

Back to top